Anti-diabetic Drugs

News - Anti-diabetic Drugs

Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe

2012-05-29 10:24:22

RIDGEFIELD, Conn.

New Research Suggests Novel Insulin Sensitizer Works Through a New Mechanism to Treat Root Cause of Type 2 Diabetes

2012-05-29 10:23:33

?KALAMAZOO, Mich., May 29, 2012 /PRNewswire/ -- A study published online in the Journal of Biological Chemistry (

FDA Approves Levemir® for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes

2012-05-22 02:28:04

PRINCETON, N.J., May 22, 2012 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that the U.S.

Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting

2012-05-22 02:26:53

NEW YORK, May 22, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that dulaglutide, its investigational, long-acting glucagon-like peptide 1 (GLP-1) analog being studied

New Drug Targeted For Diabetes

2012-05-22 02:50:34

New research from the University of Cincinnati (UC) points to the naturally produced protein apolipoprotein A-IV (apoA-IV) as a potential target for a new diabetes therapeutic.

More News (1560 articles) »